Wellington Management Group LLP Invests $408,000 in Grail, Inc. (NASDAQ:GRAL)

Wellington Management Group LLP acquired a new position in Grail, Inc. (NASDAQ:GRAL - Free Report) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm acquired 22,860 shares of the company's stock, valued at approximately $408,000. Wellington Management Group LLP owned 0.07% of Grail at the end of the most recent quarter.

Other hedge funds have also bought and sold shares of the company. C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors bought a new position in shares of Grail in the fourth quarter worth $244,000. Moloney Securities Asset Management LLC bought a new position in Grail in the 4th quarter worth about $559,000. Rhumbline Advisers purchased a new position in Grail during the 4th quarter valued at about $456,000. Wesbanco Bank Inc. bought a new stake in shares of Grail during the fourth quarter valued at about $523,000. Finally, Slow Capital Inc. purchased a new stake in shares of Grail in the fourth quarter worth about $2,379,000.

Grail Price Performance

NASDAQ GRAL traded up $0.50 during trading on Friday, reaching $27.00. The company's stock had a trading volume of 642,745 shares, compared to its average volume of 1,221,381. The firm has a fifty day moving average of $32.83 and a 200 day moving average of $23.64. Grail, Inc. has a one year low of $12.33 and a one year high of $63.99.

Grail (NASDAQ:GRAL - Get Free Report) last announced its earnings results on Thursday, February 20th. The company reported ($1.86) earnings per share (EPS) for the quarter, beating the consensus estimate of ($4.41) by $2.55. The company had revenue of $38.25 million for the quarter, compared to the consensus estimate of $35.33 million. As a group, equities analysts anticipate that Grail, Inc. will post -15.15 EPS for the current fiscal year.

Analyst Ratings Changes

Separately, Morgan Stanley boosted their price target on shares of Grail from $16.00 to $20.00 and gave the company an "equal weight" rating in a research report on Tuesday, March 18th.

Insiders Place Their Bets

In related news, CEO Robert P. Ragusa sold 7,625 shares of the stock in a transaction on Friday, March 7th. The shares were sold at an average price of $31.21, for a total transaction of $237,976.25. Following the transaction, the chief executive officer now owns 828,662 shares of the company's stock, valued at approximately $25,862,541.02. This trade represents a 0.91 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, President Joshua J. Ofman sold 2,109 shares of the business's stock in a transaction on Friday, March 7th. The stock was sold at an average price of $31.20, for a total transaction of $65,800.80. Following the completion of the sale, the president now directly owns 559,673 shares of the company's stock, valued at $17,461,797.60. This represents a 0.38 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 11,550 shares of company stock valued at $360,436 over the last quarter.

Grail Company Profile

GRAIL, Inc is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA.